A group of about 325 Canadian women who suffered ill-effects from implantation of transvaginal mesh will receive $21.5 million in compensation under a proposed class-action settlement. (Pikrepo photo)

Women with transvaginal mesh implants to share $21.5 million in settlement

Implants used to treat stress urinary incontinence, pelvic organ prolapse caused ill-effects

A group of Canadian women who suffered ill-effects from implantation of a medical device called transvaginal mesh will receive a total of $21.5 million in compensation under a proposed class-action settlement, court records show.

The settlement, between the women and Boston Scientific, involves about 325 women who received the implants. Their share of the money would depend on the severity of their medical issues.

In approving the class definition and method for reaching out to class members, Ontario Superior Court Justice Paul Perell noted the settlement is similar to another recently approved class action involving the mesh. Final approval of the current action is expected in June.

The net-like implants are used to treat conditions such as stress urinary incontinence or pelvic organ prolapse. The implants are designed to reinforce a weak vaginal wall or support the urethra or bladder neck. The polypropylene mesh is widely used. However, many recipients have had an array of serious side effects.

ALSO READ: Canadian law firm launches class action on behalf of Iran flight victims

Boston Scientific is the Canadian subsidiary of its Delaware-based parent and is the sole distributor of the company’s transvaginal mesh devices in Canada. The product has been implanted in thousands of Canadian women.

The lead plaintiff in the class action, Susan Vester, suffered painful complications from her implant. Court documents show she was given the device in January 2010 as a way to prevent incontinence — an operation about 25,000 women a year have in Canada.

Among other complications, Vester said she suffered urinary problems, difficulty walking, emotional stress and pain during sexual intercourse. She argued she was unaware of the risks before the surgery and would have refused the procedure had she known.

Vester and her husband sued Boston Scientific, alleging the devices were defective and unsafe. Among other things, they argued the mesh was negligently designed and sold, and that recipients had required intensive surgical interventions to try to alleviate the side-effects.

ALSO READ: Federal Government invests $10 million towards cervical cancer research

The company maintained her complaints were the result of pre-existing medical conditions, not the mesh. It denied the product caused the problems about which the women complained.

After initially refusing to do so in 2015, Perell certified the lawsuit as a class action in February 2017.

“There is some basis in fact that the polypropylene mesh in each of Boston Scientific’s transvaginal devices has a clinically significant deficiency,” Perell wrote at the time. “Boston Scientific’s arguments based on an alleged multiplicity of differences between the products, patients, and the complications, do not negate the commonality of the proposed common issues.”

The settlement also applies to about 20 or so women who’ve had the implants since the action was certified, and they have 60 days to opt out. Boston stopped selling the devices for treating pelvic organ prolapse last July.

Daniel Bach, the Vesters’ lawyer, said his clients were happy with the settlement, in which Boston Scientific admits no liability.

“This agreement will enable members of the class to receive compensation for the injuries they allege,” Bach said.

In an earnings call last month, the U.S. company’s chief financial officer said Boston was working to resolve litigation over the mesh. More than 95 per cent of known claims were settled or were in the final stages of settlement, Dan Brennan said. He said the company expected to pay US$115 million into settlement funds this year.

Colin Perkel, The Canadian Press

Like us on Facebook and follow us on Twitter

class-action lawsuit

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

FortisBC offers 90-day bill deferrals to customers impacted by COVID-19

Customers can apply for the relief program through the utility’s website

Kootenay Boundary doctor offices open, call first

Viral transmission precautions in place

Trail residents asked to postpone parades

Trail Mayor makes Facebook plea to stop the ‘self-distancing parades’

A message to Trail Times subscribers

Thank you and we appreciate your support during this unprecedented time in history.

Last call for Trail-Warfield Citizen of the Year nods

Submissions should be forwarded by email

COVID-19: 4 new deaths, 25 new cases but only in Vancouver Coastal, Fraser Health

A total of 1,291 people have tested positive for the novel coronavirus

COVID-19: Don’t get away for Easter weekend, Dr. Bonnie Henry warns

John Horgan, Adrian Dix call 130 faith leaders as holidays approach

COVID-19: Trudeau says 30K ventilators on the way; 3.6M Canadians claim benefits

Canada has seen more than 17,000 cases and at least 345 deaths due to COVID-19

RCMP call on kids to name latest foal recruits

The baby horses names are to start with the letter ‘S’

As Canadians return home amid pandemic, border crossings dip to just 5% of usual traffic

Non-commercial land crossing dipped by 95%, air travel dropped by 96 per cent, according to the CBSA

Logan Boulet Effect: Green Shirt Day calls on Canadians to become organ donors

While social distancing, the day also honours the 16 lives lost in the 2018 Humboldt Broncos Crash

COMMENTARY: Knowing where COVID-19 cases are does not protect you

Dr. Bonnie Henry explains why B.C. withholds community names

B.C. wide burning restrictions come into effect April 16

‘Larger open burns pose an unnecessary risk and could detract from wildfire detection’

Most Read